Epigastric pain and fever should be investigated
Food & Drug Administration showed patients on Semaglutide lost an average ~15% of their body weight, or ~35 lbs, but with longer-term yields showed results in a weight loss of ~30% Results Beyond Weight Loss May Include: Feeling better and looking better Reversal of pre-diabetic conditions Enhanced emotional health, mental clarity, and improved mood Lower blood pressure Lower triglycerides Less risk of heart disease Improved insulin resistance Lowered risk for multiple cancers More energy Enhanced immune system Improved mobility, and reduced pain Higher self-esteem Improved eating habits Enhanced sex life and less erectile dysfunction Balanced hormones Better sleep FDA DISCLAIMER The statements made regarding these products have not been evaluated by the Food and Drug Administration
Storage Store unreconstituted vials at 2 8 C
You Are Still in the Dose Adjustment Phase Many patients begin at a low dose that is not intended to fully suppress appetite
Two patients on identical medications can have very different outcomes based on adherence alone
If the peptide is impure, contains residual solvents from a sloppy manufacturing process, or has an incorrect amino acid sequence, your research is doomed before it even begins
